Cargando…

A randomized half-body, double blind, controlled trial on the effects of a pH-modified moisturizer vs. standard moisturizer in mild to moderate atopic dermatitis()()

BACKGROUND: Higher skin pH in atopic dermatitis contributes to impaired epidermal barrier. A moisturizer compatible with physiological pH could improve atopic dermatitis. OBJECTIVE: To determine the effect of a physiologically compatible pH moisturizer in atopic dermatitis. METHODS: A randomized hal...

Descripción completa

Detalles Bibliográficos
Autores principales: Goh, Siew Wen, Jamil, Adawiyah, Safian, Nazarudin, Md Nor, Norazirah, Muhammad, Norliza, Saharudin, Nur Liyana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Dermatologia 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7253898/
https://www.ncbi.nlm.nih.gov/pubmed/32291095
http://dx.doi.org/10.1016/j.abd.2019.11.007
_version_ 1783539419515453440
author Goh, Siew Wen
Jamil, Adawiyah
Safian, Nazarudin
Md Nor, Norazirah
Muhammad, Norliza
Saharudin, Nur Liyana
author_facet Goh, Siew Wen
Jamil, Adawiyah
Safian, Nazarudin
Md Nor, Norazirah
Muhammad, Norliza
Saharudin, Nur Liyana
author_sort Goh, Siew Wen
collection PubMed
description BACKGROUND: Higher skin pH in atopic dermatitis contributes to impaired epidermal barrier. A moisturizer compatible with physiological pH could improve atopic dermatitis. OBJECTIVE: To determine the effect of a physiologically compatible pH moisturizer in atopic dermatitis. METHODS: A randomized half body, double blind, controlled trial involving patients with stable atopic dermatitis was performed. pH-modified moisturizer and standard moisturizer were applied to half body for 6 weeks. RESULTS: A total of 6 (16.7%) males and 30 (83.3%) females participated. Skin pH reductions from week 0, week 2 and 6 were significant at the forearms (5.315 [0.98] to 4.85 [0.54] to 5.04 [0.78], p = 0.02) and abdomen (5.25 [1.01], 4.82 [0.64], 5.01 [0.59], p = 0.00) but not at the shins (5.01 [0.80], 4.76 [0.49], 4.85 [0.79], p = 0.09) with pH-modified moisturizer. Transepidermal water loss (TEWL) at the forearms decreased (4.60 [2.55] to 3.70 [3.10] to 3.00 [3.55], p = 0.00), abdomen (3.90 [2.90] to 2.40 [3.45] to 2.70 [2.25], p = 0.046). SCORAD improved from 14.1 ± 12.75 to 10.5 ± 13.25 to 7 ± 12.25, p = 0.00. In standard moisturizer group, pH reductions were significant at the forearms (5.29 [0.94] to 4.84 [0.55] to 5.02 [0.70], p = 0.00) and abdomen (5.25 [1.09], 4.91 [0.63], 5.12 [0.66], p = 0.00). TEWL at the forearm were (4.80 [2.95], 4.10 [2.15], 4.60 [3.40], p = 0.67), shins (3.80 [1.40], 3.50 [2.35], 4.00 [2.50], p = 0.91) and abdomen (3.70 [2.45], 4.10 [3.60], 3.40 [2.95], p = 0.80). SCORAD improved from 14.2 ± 9.1 to 10.9 ± 10.65 to 10.5 ± 11, p = 0.00. Reduction in pH was observed with both moisturizers while TEWL significantly improved with pH-modified moisturizer. pH-modified moisturizer resulted in greater pH, TEWL and SCORAD improvements however the differences were not significant from standard moisturizer. STUDY LIMITATION: Skin hydration was not evaluated. CONCLUSION: Moisturization is beneficial for atopic dermatitis; use of physiologically compatible pH moisturizer is promising.
format Online
Article
Text
id pubmed-7253898
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Sociedade Brasileira de Dermatologia
record_format MEDLINE/PubMed
spelling pubmed-72538982020-06-01 A randomized half-body, double blind, controlled trial on the effects of a pH-modified moisturizer vs. standard moisturizer in mild to moderate atopic dermatitis()() Goh, Siew Wen Jamil, Adawiyah Safian, Nazarudin Md Nor, Norazirah Muhammad, Norliza Saharudin, Nur Liyana An Bras Dermatol Investigation BACKGROUND: Higher skin pH in atopic dermatitis contributes to impaired epidermal barrier. A moisturizer compatible with physiological pH could improve atopic dermatitis. OBJECTIVE: To determine the effect of a physiologically compatible pH moisturizer in atopic dermatitis. METHODS: A randomized half body, double blind, controlled trial involving patients with stable atopic dermatitis was performed. pH-modified moisturizer and standard moisturizer were applied to half body for 6 weeks. RESULTS: A total of 6 (16.7%) males and 30 (83.3%) females participated. Skin pH reductions from week 0, week 2 and 6 were significant at the forearms (5.315 [0.98] to 4.85 [0.54] to 5.04 [0.78], p = 0.02) and abdomen (5.25 [1.01], 4.82 [0.64], 5.01 [0.59], p = 0.00) but not at the shins (5.01 [0.80], 4.76 [0.49], 4.85 [0.79], p = 0.09) with pH-modified moisturizer. Transepidermal water loss (TEWL) at the forearms decreased (4.60 [2.55] to 3.70 [3.10] to 3.00 [3.55], p = 0.00), abdomen (3.90 [2.90] to 2.40 [3.45] to 2.70 [2.25], p = 0.046). SCORAD improved from 14.1 ± 12.75 to 10.5 ± 13.25 to 7 ± 12.25, p = 0.00. In standard moisturizer group, pH reductions were significant at the forearms (5.29 [0.94] to 4.84 [0.55] to 5.02 [0.70], p = 0.00) and abdomen (5.25 [1.09], 4.91 [0.63], 5.12 [0.66], p = 0.00). TEWL at the forearm were (4.80 [2.95], 4.10 [2.15], 4.60 [3.40], p = 0.67), shins (3.80 [1.40], 3.50 [2.35], 4.00 [2.50], p = 0.91) and abdomen (3.70 [2.45], 4.10 [3.60], 3.40 [2.95], p = 0.80). SCORAD improved from 14.2 ± 9.1 to 10.9 ± 10.65 to 10.5 ± 11, p = 0.00. Reduction in pH was observed with both moisturizers while TEWL significantly improved with pH-modified moisturizer. pH-modified moisturizer resulted in greater pH, TEWL and SCORAD improvements however the differences were not significant from standard moisturizer. STUDY LIMITATION: Skin hydration was not evaluated. CONCLUSION: Moisturization is beneficial for atopic dermatitis; use of physiologically compatible pH moisturizer is promising. Sociedade Brasileira de Dermatologia 2020 2020-03-21 /pmc/articles/PMC7253898/ /pubmed/32291095 http://dx.doi.org/10.1016/j.abd.2019.11.007 Text en © 2020 Sociedade Brasileira de Dermatologia. Published by Elsevier España, S.L.U. http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Investigation
Goh, Siew Wen
Jamil, Adawiyah
Safian, Nazarudin
Md Nor, Norazirah
Muhammad, Norliza
Saharudin, Nur Liyana
A randomized half-body, double blind, controlled trial on the effects of a pH-modified moisturizer vs. standard moisturizer in mild to moderate atopic dermatitis()()
title A randomized half-body, double blind, controlled trial on the effects of a pH-modified moisturizer vs. standard moisturizer in mild to moderate atopic dermatitis()()
title_full A randomized half-body, double blind, controlled trial on the effects of a pH-modified moisturizer vs. standard moisturizer in mild to moderate atopic dermatitis()()
title_fullStr A randomized half-body, double blind, controlled trial on the effects of a pH-modified moisturizer vs. standard moisturizer in mild to moderate atopic dermatitis()()
title_full_unstemmed A randomized half-body, double blind, controlled trial on the effects of a pH-modified moisturizer vs. standard moisturizer in mild to moderate atopic dermatitis()()
title_short A randomized half-body, double blind, controlled trial on the effects of a pH-modified moisturizer vs. standard moisturizer in mild to moderate atopic dermatitis()()
title_sort randomized half-body, double blind, controlled trial on the effects of a ph-modified moisturizer vs. standard moisturizer in mild to moderate atopic dermatitis()()
topic Investigation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7253898/
https://www.ncbi.nlm.nih.gov/pubmed/32291095
http://dx.doi.org/10.1016/j.abd.2019.11.007
work_keys_str_mv AT gohsiewwen arandomizedhalfbodydoubleblindcontrolledtrialontheeffectsofaphmodifiedmoisturizervsstandardmoisturizerinmildtomoderateatopicdermatitis
AT jamiladawiyah arandomizedhalfbodydoubleblindcontrolledtrialontheeffectsofaphmodifiedmoisturizervsstandardmoisturizerinmildtomoderateatopicdermatitis
AT safiannazarudin arandomizedhalfbodydoubleblindcontrolledtrialontheeffectsofaphmodifiedmoisturizervsstandardmoisturizerinmildtomoderateatopicdermatitis
AT mdnornorazirah arandomizedhalfbodydoubleblindcontrolledtrialontheeffectsofaphmodifiedmoisturizervsstandardmoisturizerinmildtomoderateatopicdermatitis
AT muhammadnorliza arandomizedhalfbodydoubleblindcontrolledtrialontheeffectsofaphmodifiedmoisturizervsstandardmoisturizerinmildtomoderateatopicdermatitis
AT saharudinnurliyana arandomizedhalfbodydoubleblindcontrolledtrialontheeffectsofaphmodifiedmoisturizervsstandardmoisturizerinmildtomoderateatopicdermatitis
AT gohsiewwen randomizedhalfbodydoubleblindcontrolledtrialontheeffectsofaphmodifiedmoisturizervsstandardmoisturizerinmildtomoderateatopicdermatitis
AT jamiladawiyah randomizedhalfbodydoubleblindcontrolledtrialontheeffectsofaphmodifiedmoisturizervsstandardmoisturizerinmildtomoderateatopicdermatitis
AT safiannazarudin randomizedhalfbodydoubleblindcontrolledtrialontheeffectsofaphmodifiedmoisturizervsstandardmoisturizerinmildtomoderateatopicdermatitis
AT mdnornorazirah randomizedhalfbodydoubleblindcontrolledtrialontheeffectsofaphmodifiedmoisturizervsstandardmoisturizerinmildtomoderateatopicdermatitis
AT muhammadnorliza randomizedhalfbodydoubleblindcontrolledtrialontheeffectsofaphmodifiedmoisturizervsstandardmoisturizerinmildtomoderateatopicdermatitis
AT saharudinnurliyana randomizedhalfbodydoubleblindcontrolledtrialontheeffectsofaphmodifiedmoisturizervsstandardmoisturizerinmildtomoderateatopicdermatitis